Skip to main content
. 2020 Apr 15;87(3):573–583. doi: 10.1093/neuros/nyaa091

TABLE 4.

Comparisons of Concussion Symptom Prevalence, Symptom Resolution Time, Return-to-Play Time, and Symptom Counts Between New and Recurrent SRCs Among High School Athletes in 20 Sports, 2013/14-2017/18 Academic Years

History
Symptom prevalence, % (95% CI) Recurrent New P valuea
Amnesia 11.6 (9.3,13.8) 11.5 (10.8,12.2) .95
Confusion/disorientation 36.6 (33.3,40.0) 37.2 (36.2,38.2) .74
Difficulty concentrating 54.1 (50.6,57.6) 56.2 (55.2,57.3) .25
Dizziness/unsteadiness 73.8 (70.8,76.9) 73.9 (72.9,74.8) .99
Drowsiness 30.9 (27.7,34.2) 32.9 (31.9,33.9) .26
Foggy 18.9 (16.1,21.6) 19.2 (18.4,20.1) .80
Headache 95.4 (93.9,96.8) 94.5 (94.0,94.9) .29
Hyperexcitability 1.9 (0.9,2.8) 2.2 (1.8,2.5) .63
Irritability 14.5 (12.0,16.9) 13.2 (12.5,13.9) .31
Light sensitivity 53.3 (49.9,56.8) 52.6 (51.5,53.6) .68
Loss of consciousness 2.3 (1.2,3.3) 2.5 (2.2,2.8) .66
Nausea 29.8 (26.6,33.0) 28.1 (27.2,29.1) .31
Noise sensitivity 36.9 (33.5,40.2) 34.6 (33.6,35.6) .19
Tinnitus 6.2 (4.5,7.8) 6.4 (5.9,7.0) .76
Other 9.3 (7.3,11.3) 8.2 (7.6,8.8) .27
Symptom resolution time, %
 <7 d 47.4 (44.0,50.9) 51.6 (50.6,52.7) .02
 >21 d 12.0 (9.7,14.2) 5.8 (5.3,6.2) <.001
Return-to-play time, %
 <7 d 7.6 (5.7,9.4) 7.9 (7.3,8.5) .72
 >21 db 15.9 (13.3,18.4) 9.4 (8.7,10.0) <.001
Symptom mean 4.8 4.7
±SD 2.3 2.4
Median 4.0 4.0 .69
IQR 3.0-6.0 3.0-6.0
Total (n) 795 8668 n/a

aP-values correspond to χ2 tests (or Fisher's exact tests when χ2 assumptions were violated) for comparing symptom prevalences and proportions for symptom resolution time and return-to-play time; and Wilcoxon rank-sum tests comparing symptom counts.

bIncludes SRCs resulting in medical disqualification for the season or career.

Note: Statistical significance was evaluated at the 0.001 level, accounting for the multiple comparisons involved. Also, as clinicians were presented with a subset of options for symptom selection, all reported concussions were retained for analysis even if no associated symptoms were reported.